Buy or sell Foundation Medicine stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Acquired
Foundation Medicine Stock
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
About Foundation Medicine Stock
Foundation Medicine plans to create clinical diagnostic tests that can use the latest in genetic sequencing technology to identify personalized cancer therapies for patients.
Funding History
| April 2010 | $7.0M |
|---|---|
| October 2011 | $33.5M |
| September 2012 | $42.5M |
| January 2013 | $13.5M |
Management
Vice President of Knowledge Informatics
Eric Neumann
Medical Director, Interim Head of Pathology & Molecular Diagnostics
Jeffrey Ross
President & CEO
Michael J. Pellini
Chief Business Officer
Steven J. Kafka
Co - Founder & Chairman of the Board
Alexis Borisy
CIO
Ronald Collette
VP, Finance
Jason Ryan
VP, Human Resources
Sarah Larson
Leader, Cancer Immunotherapy
David Fabrizio
Chief Commercial Officer & SVP, International Strategy
Kevin Krenitsky
Press
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
